P2X4 Purinergic Receptors as a Therapeutic Target in Aggressive Prostate Cancer
J. P. Maynard, J. Lu, I. Vidal, J. Hicks, L. Mummert, T. Ali, R. Kempski, A. M. Carter, R. Sosa, L. B. Peiffer, C. E. Joshu, T. L. Lotan, A. M. De Marzo, K. S. Sfanos
This study identifies P2X4 purinergic receptors as a driver of aggressive prostate cancer and a potential therapeutic target through in vitro and in vivo experiments.
bioRxiv · Jun 4, 2021Cancer Biology